The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
It was the insistent questioning of my four-year-old grandson that goaded me into it. “Why is your tummy so big” he asked ...